AU4655199A - Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate - Google Patents
Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfateInfo
- Publication number
- AU4655199A AU4655199A AU46551/99A AU4655199A AU4655199A AU 4655199 A AU4655199 A AU 4655199A AU 46551/99 A AU46551/99 A AU 46551/99A AU 4655199 A AU4655199 A AU 4655199A AU 4655199 A AU4655199 A AU 4655199A
- Authority
- AU
- Australia
- Prior art keywords
- sucralfate
- therapeutic effect
- pharmaceutical preparation
- gastrointestinal disorders
- orally administrable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR1999/000327 WO2000078307A1 (en) | 1999-06-21 | 1999-06-21 | Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4655199A true AU4655199A (en) | 2001-01-09 |
Family
ID=19570891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46551/99A Abandoned AU4655199A (en) | 1999-06-21 | 1999-06-21 | Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR100453179B1 (en) |
CN (1) | CN1173698C (en) |
AU (1) | AU4655199A (en) |
WO (1) | WO2000078307A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103702A2 (en) * | 2005-04-01 | 2006-10-05 | Mccullough Ricky W | Enhanced bio-adherent polymeric compositions for coating mucosal and epidermal epithelium |
CN101507717B (en) * | 2009-03-13 | 2013-01-23 | 沈阳药科大学 | Composite tablet capable of treating peptic ulcer and preparation method thereof |
CN101607086B (en) * | 2009-07-21 | 2011-11-02 | 山西安特生物制药股份有限公司 | Compound bismuth composition and preparation method thereof |
KR101583452B1 (en) | 2015-01-30 | 2016-01-11 | 주식회사 대웅제약 | A pharmaceutical composition for treating gastrointestinal diseases |
KR101801064B1 (en) | 2015-07-20 | 2017-11-27 | 안국약품 주식회사 | Three-layered tablet for treating stomach and intestines disease |
KR101794529B1 (en) * | 2016-06-14 | 2017-11-07 | 주식회사 인트로바이오파마 | Film-coated tablet for gastrointestinal disease, and method of preparing the same |
KR20230156474A (en) | 2022-05-06 | 2023-11-14 | 에니솔루션 주식회사 | Composite tablet for treating stomach and intestines disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0403048A3 (en) * | 1989-06-14 | 1991-01-30 | Warner-Lambert Company | Medicated compositions containing sucralfate and processes for their production |
JP3677376B2 (en) * | 1996-08-13 | 2005-07-27 | 武田薬品工業株式会社 | Medicine |
-
1999
- 1999-06-21 WO PCT/KR1999/000327 patent/WO2000078307A1/en active IP Right Grant
- 1999-06-21 KR KR10-2001-7016389A patent/KR100453179B1/en not_active IP Right Cessation
- 1999-06-21 CN CNB998167568A patent/CN1173698C/en not_active Expired - Lifetime
- 1999-06-21 AU AU46551/99A patent/AU4655199A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1173698C (en) | 2004-11-03 |
KR20020031342A (en) | 2002-05-01 |
CN1354660A (en) | 2002-06-19 |
WO2000078307A1 (en) | 2000-12-28 |
KR100453179B1 (en) | 2004-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9912979B1 (en) | orally administrable pharmaceutical composition, chewing tablet, capsule and use of chitosan. | |
HK1035142A1 (en) | Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent. | |
AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
PL351526A1 (en) | Pharmaceutical formulation comprising amoxycillin | |
AU2002365516A1 (en) | Benzamide derivatives, processes for their preparation, and their pharmaceutical use | |
AU2922600A (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
AU4328800A (en) | Pharmaceutical formulation | |
ZA200308221B (en) | Pharmaceutical compositions for oral and topical administration. | |
AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
AU9551298A (en) | Use of coumarin derivatives for the treatment of digestive tract disorders | |
AU4655199A (en) | Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate | |
ZA200203294B (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them. | |
AU3971500A (en) | Indazole derivatives, preparation and therapeutic application thereof | |
AU1751997A (en) | Targeted delivery of drugs to the lower gastrointestinal tract | |
AUPQ462299A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU6092698A (en) | Combination preparation for orally administered antibiotics | |
AU3839900A (en) | Pharmaceutical formulation | |
GB9910773D0 (en) | Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract | |
AU3444299A (en) | Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders | |
AU1388501A (en) | Pharmaceutical formulation | |
HK1047104A1 (en) | Spiroimidazolidine derivatives, their preparation,their use and pharmaceutical preparations compris ing them | |
AU1172101A (en) | Phytoestrogenic pharmaceutical preparations | |
IL146372A0 (en) | Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them | |
AU3989100A (en) | Pharmaceutical gel formulation | |
AU4996699A (en) | Immunosupportive drug sparing diet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |